New Treatment Option for Relapsing Multiple Sclerosis
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Priority Review Puts Satralizumab on Track as First MOGAD Drug
2
NeuroVoices: Jacqueline Becker, PhD, on Brain Fog, Alzheimer Risk, and Treatment Advances in Long COVID
3
Long-Term Data Shows Trade-off Between Daily, Intermittent Corticosteroids in Patients With Duchenne
4
Del-Desiran Fails to Meet Primary Endpoint in Phase 3 HARBOR Trial of Myotonic Dystrophy 1
5